Onderwerp

Nash

1 artikel gevonden

ACR 2018: Video met Peter Nash, University of Queensland, Brisbane, Australia

2565: Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patient ...